Alfonso Piciocchi | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: report from the Multiple Myeloma Gimema Lazio Group	EUROPEAN JOURNAL OF HAEMATOLOGY	2022
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study	CANCERS	2022
The Addition of Venetoclax to Induction Chemotherapy in No Low-Risk AML Patients: A Propensity Score-Matched Analysis of the Gimema AML1718 and AML1310 Trials	BLOOD	2022
Health-Related Quality of Life and Financial Burden of Ethiopian Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors	BLOOD	2022
Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case-control study	EUROPEAN JOURNAL OF HAEMATOLOGY	2022
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. a retrospective multicentric gimema study	HAEMATOLOGICA	2022
A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients. Final results of the GIMEMA LAL1509 protocol	HAEMATOLOGICA	2021
Relapsed/Refractory Multiple Myeloma Patients. A Multicenter Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy	BLOOD	2021
TH2/TH1 shift under Ibrutinib treatment in chronic lymphocytic leukemia	FRONTIERS IN ONCOLOGY	2021
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996	AMERICAN JOURNAL OF HEMATOLOGY	2021
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial	AMERICAN JOURNAL OF HEMATOLOGY	2021
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters	BRITISH JOURNAL OF HAEMATOLOGY	2021
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations	BRITISH JOURNAL OF HAEMATOLOGY	2020
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)	HAEMATOLOGICA	2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimale residual disease-oriented GIMEMA LAL1913	HAEMATOLOGICA	2020
Screening policies, preventive measures and in-hospital infection of COVID-19 in global surgical practices	JOURNAL OF GLOBAL HEALTH	2020
Screening policies, preventive measures and in-hospital infection of COVID-19 in global surgical practice	JOURNAL OF GLOBAL HEALTH	2020
Screening policies, preventive measures and in-hospital infection of COVID-19 in global surgical practices	JOURNAL OF GLOBAL HEALTH	2020
Dasatinib-blinatumomab for ph-positive acute lymphoblastic leukemia in adults	NEW ENGLAND JOURNAL OF MEDICINE	2020
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey	LEUKEMIA	2020